Rebecca Elaine Cagnina, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myelomonocytic, Acute | 1 | 2020 | 39 | 0.750 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2021 | 174 | 0.750 |
Why?
|
| Leukemic Infiltration | 1 | 2020 | 48 | 0.740 |
Why?
|
| Fungi | 1 | 2021 | 327 | 0.660 |
Why?
|
| Acute Lung Injury | 1 | 2021 | 380 | 0.610 |
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 2015 | 29 | 0.530 |
Why?
|
| Cystic Fibrosis | 2 | 2021 | 1178 | 0.520 |
Why?
|
| Pneumonia, Bacterial | 4 | 2022 | 316 | 0.490 |
Why?
|
| Pericardial Effusion | 1 | 2016 | 247 | 0.460 |
Why?
|
| Receptor, Adenosine A2B | 2 | 2012 | 33 | 0.460 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 1344 | 0.430 |
Why?
|
| Neutrophils | 3 | 2021 | 3717 | 0.390 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2016 | 582 | 0.370 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 4419 | 0.360 |
Why?
|
| Pulmonary Alveoli | 1 | 2009 | 675 | 0.280 |
Why?
|
| Lung | 4 | 2022 | 9852 | 0.260 |
Why?
|
| Klebsiella pneumoniae | 3 | 2017 | 251 | 0.250 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 20123 | 0.250 |
Why?
|
| Benzodioxoles | 2 | 2021 | 69 | 0.240 |
Why?
|
| Aminophenols | 2 | 2021 | 78 | 0.230 |
Why?
|
| Klebsiella Infections | 2 | 2016 | 138 | 0.230 |
Why?
|
| Pulmonary Embolism | 1 | 2016 | 2375 | 0.220 |
Why?
|
| Quinolones | 2 | 2021 | 367 | 0.190 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2022 | 227 | 0.190 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2023 | 139 | 0.190 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2022 | 248 | 0.180 |
Why?
|
| Rabies virus | 1 | 2019 | 39 | 0.170 |
Why?
|
| Influenza A virus | 1 | 2022 | 457 | 0.160 |
Why?
|
| Rabies | 1 | 2019 | 61 | 0.160 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2023 | 329 | 0.160 |
Why?
|
| Fish Oils | 1 | 2022 | 470 | 0.160 |
Why?
|
| Pneumococcal Infections | 1 | 2022 | 497 | 0.150 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3690 | 0.150 |
Why?
|
| Aminopyridines | 1 | 2021 | 542 | 0.150 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2016 | 56 | 0.140 |
Why?
|
| Pericardiocentesis | 1 | 2016 | 74 | 0.130 |
Why?
|
| Indoles | 2 | 2021 | 1838 | 0.130 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2016 | 186 | 0.130 |
Why?
|
| Drug Combinations | 1 | 2021 | 1962 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 4752 | 0.130 |
Why?
|
| Respiratory Tract Infections | 1 | 2022 | 961 | 0.130 |
Why?
|
| Remission, Spontaneous | 1 | 2015 | 380 | 0.130 |
Why?
|
| Cardiac Tamponade | 1 | 2016 | 173 | 0.120 |
Why?
|
| Phagocytes | 1 | 2016 | 297 | 0.120 |
Why?
|
| Hypoglycemia | 1 | 2021 | 861 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 2078 | 0.120 |
Why?
|
| Shock | 1 | 2016 | 318 | 0.110 |
Why?
|
| Angina Pectoris | 1 | 2016 | 977 | 0.100 |
Why?
|
| Influenza, Human | 1 | 2022 | 1480 | 0.100 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2009 | 30 | 0.090 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2009 | 48 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2021 | 14556 | 0.090 |
Why?
|
| Mice | 9 | 2023 | 81178 | 0.080 |
Why?
|
| Iron | 1 | 2017 | 1774 | 0.080 |
Why?
|
| beta-Galactosidase | 1 | 2009 | 573 | 0.080 |
Why?
|
| Dyspnea | 1 | 2016 | 1303 | 0.080 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2007 | 124 | 0.070 |
Why?
|
| Lung Injury | 1 | 2011 | 436 | 0.070 |
Why?
|
| Inflammation | 2 | 2023 | 10634 | 0.070 |
Why?
|
| Cyclic AMP | 1 | 2009 | 1471 | 0.060 |
Why?
|
| Bronchi | 1 | 2009 | 840 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2009 | 1547 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 7908 | 0.060 |
Why?
|
| Animals | 10 | 2023 | 168788 | 0.060 |
Why?
|
| Pneumonia, Viral | 1 | 2023 | 3239 | 0.060 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2007 | 675 | 0.060 |
Why?
|
| Macrophages | 3 | 2022 | 5657 | 0.060 |
Why?
|
| Leukocytes | 1 | 2011 | 2040 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2009 | 1504 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2017 | 767 | 0.050 |
Why?
|
| Humans | 9 | 2022 | 744220 | 0.050 |
Why?
|
| Liver | 1 | 2016 | 7472 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 2216 | 0.040 |
Why?
|
| Sheep | 1 | 2022 | 1437 | 0.040 |
Why?
|
| Pyrrolidines | 1 | 2021 | 342 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 6612 | 0.040 |
Why?
|
| Cell Movement | 1 | 2011 | 5216 | 0.040 |
Why?
|
| Virginia | 1 | 2019 | 121 | 0.040 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2021 | 437 | 0.040 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2021 | 434 | 0.040 |
Why?
|
| Bites and Stings | 1 | 2019 | 91 | 0.040 |
Why?
|
| Dog Diseases | 1 | 2019 | 138 | 0.040 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2019 | 102 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2012 | 21824 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 5867 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2007 | 1885 | 0.040 |
Why?
|
| Streptococcus pneumoniae | 1 | 2022 | 714 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2009 | 13036 | 0.040 |
Why?
|
| Bone Marrow Cells | 2 | 2016 | 2513 | 0.040 |
Why?
|
| Contact Tracing | 1 | 2019 | 273 | 0.030 |
Why?
|
| Biological Availability | 1 | 2017 | 396 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2023 | 875 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2023 | 1221 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2023 | 2617 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1849 | 0.030 |
Why?
|
| Dogs | 1 | 2019 | 3913 | 0.030 |
Why?
|
| India | 1 | 2019 | 2199 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2021 | 1973 | 0.020 |
Why?
|
| Female | 3 | 2020 | 380197 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 12075 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2023 | 2958 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 163253 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 57768 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2012 | 407 | 0.020 |
Why?
|
| Pyridines | 1 | 2021 | 2822 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2011 | 5974 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2011 | 1584 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2021 | 6259 | 0.020 |
Why?
|
| Monocytes | 1 | 2016 | 2594 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2016 | 1978 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2016 | 2944 | 0.020 |
Why?
|
| Male | 4 | 2022 | 350027 | 0.020 |
Why?
|
| Transplantation Chimera | 1 | 2007 | 612 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 2007 | 798 | 0.010 |
Why?
|
| Chemokines | 1 | 2007 | 969 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 213367 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2011 | 2725 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3871 | 0.010 |
Why?
|
| Pneumonia | 1 | 2011 | 2134 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 11368 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 19907 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 23404 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 214035 | 0.000 |
Why?
|